• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Dec 4;S1198-743X(20)30729-1.
doi: 10.1016/j.cmi.2020.11.033. Online ahead of print.
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases


Dietrich Mack[SUP] 1 [/SUP], Barbara Christine G?rtner[SUP] 2 [/SUP], Annika R?ssler[SUP] 3 [/SUP], Janine Kimpel[SUP] 4 [/SUP], Katrin Donde[SUP] 5 [/SUP], Oliver Harzer[SUP] 6 [/SUP], Werner Krutsch[SUP] 7 [/SUP], Dorothee von Laer[SUP] 8 [/SUP], Tim Meyer[SUP] 9 [/SUP]



Affiliations

Abstract

Objectives: Elite professional football players and staff are a unique group that might give insight into the epidemiology of SARS-CoV-2 infections in Germany and thus can serve as a model for a geographical distribution and an estimation of undetected infections.
Methods: In this prospective cohort study seroprevalence was determined twice in May and June 2020 in players and staff from German Bundesliga. As screening assays a commercial ELISA (Euroimmun) and a CLIA (Roche) was used and an in-house neutralisation assay (NT) as gold standard. Participants were tested twice weekly using PCR from nasopharyngeal and/or oropharyngeal swabs.
Results: Seroprevalence (NT used as confirmation) in 2,164 samples from 1,184 players and staff was rather similar in May (23/1157 (1.99%)) and in June (21/1007 (2.09%)). All participants were PCR negative during the study period. Significant regional differences in seroprevalence were not observed. When comparing seroprevalence with the cumulative incidence of infections derived from the German notification system (subgroup matching to cohort; men, age: 20-69), IgG was found 8-10 times more frequently, pointing to a high rate of undetected infections. ELISA and CLIA correlated only moderately (Kappa 0.52).
Conclusions: Seroprevalence with high quality diagnostic in Germany seemed to be around 2%. The number of undetected infections seems to be 8-10 times higher than notification data. Quality of antibody assays is rather variable, thus results should ideally be confirmed at least by a second assay to prove IgG positivity.

Keywords: CLIA; COVID-19; Coronavirus; ELISA; Emerging virus; Epidemiology; IgG; Immunity; Neutralisation assay; SARS-CoV-2; Shutdown; Soccer.
 
Back
Top Bottom